Abstract

Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author

More From: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Paper Title
Journal
Date
Author
Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
Daniel N Wolfe ... Huyen Cao
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Daniel N Wolfe, et. al.Daniel N Wolfe ... Huyen Cao
28 May 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
Joshua A Hill ... Miguel-Angel Perales
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Joshua A Hill, et. al.Joshua A Hill ... Miguel-Angel Perales
27 May 2024
Position of the Infectious Diseases Society of America and the HIV Medicine Association on Team-Based Infectious Diseases Care and the Roles of Advanced Practice Providers and Clinical Pharmacists.
Andrea Weddle
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Andrea WeddleAndrea Weddle
27 May 2024
Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
Keerthi Anpalagan ...
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Keerthi Anpalagan, et. al.Keerthi Anpalagan ...
27 May 2024
View more papers